LUKAS BIOMEDICAL INC.

 

Area: Cell Therapy and Regenerative Medicine

Booth No: M220

Website: https://lukas-bio.com.tw/

 

Exhibitor Profile

 

Lukas’ primary memory T cell technology is developed in collaboration with the National Cancer Center of Japan. The technology has been validated through 2 Phase III clinical trials in Japan and Korea and has been certified by Korea FDA. Post-marketing Phase IV clinical trial data is therefore available validating the efficacy of our technology and more than 10,000 people have received such Memory T cell treatment in Japan and Korea and Taiwan.

 

Brands

 

Lukas Biomedical Inc.

 

Video

 

• 

  Lukas Biomedical｜Company Brand Video｜Immune Cell Therapy｜Memory T Cells

 

 

Exhibit Products

 

• 

  Lulym-T

 

 

 

back